JP2005527477A5 - - Google Patents

Download PDF

Info

Publication number
JP2005527477A5
JP2005527477A5 JP2003528823A JP2003528823A JP2005527477A5 JP 2005527477 A5 JP2005527477 A5 JP 2005527477A5 JP 2003528823 A JP2003528823 A JP 2003528823A JP 2003528823 A JP2003528823 A JP 2003528823A JP 2005527477 A5 JP2005527477 A5 JP 2005527477A5
Authority
JP
Japan
Prior art keywords
disease
pharmaceutical composition
mammal
treating
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003528823A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005527477A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/030089 external-priority patent/WO2003024976A2/en
Publication of JP2005527477A publication Critical patent/JP2005527477A/ja
Publication of JP2005527477A5 publication Critical patent/JP2005527477A5/ja
Withdrawn legal-status Critical Current

Links

JP2003528823A 2001-09-21 2002-09-19 ５‐ｈｔリガンドとしての三環性インドール誘導体 Withdrawn JP2005527477A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32366601P 2001-09-21 2001-09-21
PCT/US2002/030089 WO2003024976A2 (en) 2001-09-21 2002-09-19 Tricyclic indole derivatives as 5-ht ligands

Publications (2)

Publication Number Publication Date
JP2005527477A JP2005527477A (ja) 2005-09-15
JP2005527477A5 true JP2005527477A5 (OSRAM) 2006-01-05

Family

ID=23260193

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003528823A Withdrawn JP2005527477A (ja) 2001-09-21 2002-09-19 ５‐ｈｔリガンドとしての三環性インドール誘導体

Country Status (8)

Country Link
US (1) US6887868B2 (OSRAM)
EP (1) EP1429776A2 (OSRAM)
JP (1) JP2005527477A (OSRAM)
AU (1) AU2002336749A1 (OSRAM)
BR (1) BR0212676A (OSRAM)
CA (1) CA2460126A1 (OSRAM)
MX (1) MXPA04002615A (OSRAM)
WO (1) WO2003024976A2 (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2004000826A1 (es) 2003-04-25 2005-03-04 Pfizer Uso de un agonista para el receptor 5-ht2c para preparar un medicamento util en el tratamiento de la incontinencia urinaria provocada por estres, con la condicion de que el agonista no sea 1-[6-cloro-5-(trifluorometil)-2-piridinil]piperazina (org-129
EP1792629A4 (en) 2004-08-25 2010-08-25 Takeda Pharmaceutical MEANS FOR THE PREVENTION / TREATMENT OF STRESS-RELATED HARNINE INCONTINENCE AND PRECAUTIONARY METHOD FOR THIS
AR059356A1 (es) * 2006-02-14 2008-03-26 Astrazeneca Ab Nuevos radioligandos
EP2727585A1 (en) 2006-05-16 2014-05-07 Takeda Pharmaceutical Company Limited In-vivo screening method
EP2216023A4 (en) 2007-11-15 2013-03-13 Takeda Pharmaceutical CONDENSED PYRIDINE DERIVATIVE AND ITS USE
JPWO2011071136A1 (ja) 2009-12-11 2013-04-22 アステラス製薬株式会社 線維筋痛症治療剤
US9216998B2 (en) * 2012-02-15 2015-12-22 Janssen Pharmaceutica Nv Tricyclic indole derivatives useful endothelial lipase inhibitors
SG11202002032SA (en) 2017-09-22 2020-04-29 Jubilant Epipad LLC Heterocyclic compounds as pad inhibitors
CA3076476A1 (en) 2017-10-18 2019-04-25 Jubilant Epipad LLC Imidazo-pyridine compounds as pad inhibitors
BR112020008851A2 (pt) 2017-11-06 2020-10-20 Jubilant Prodel LLC composto da fórmula i, processo de preparação de compostos da fórmula i, composição farmacêutica, método para o tratamento e/ou prevenção de várias doenças, uso, método para o tratamento de câncer, método de tratamento de câncer e método para o tratamento e/ou prevenção de câncer e doenças infecciosas
PL3704120T3 (pl) 2017-11-24 2024-09-16 Jubilant Episcribe Llc Związki heterocykliczne jako inhibitory prmt5
JPWO2019131902A1 (ja) 2017-12-27 2020-12-10 武田薬品工業株式会社 腹圧性尿失禁および便失禁の治療薬
SG11202008950PA (en) 2018-03-13 2020-10-29 Jubilant Prodel LLC Bicyclic compounds as inhibitors of pd1/pd-l1 interaction/activation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3914421A (en) * 1972-06-19 1975-10-21 Endo Lab Pyridopyrrolobenzheterocycles for combatting depression
US4219550A (en) * 1978-11-09 1980-08-26 E. I. Du Pont De Nemours And Company Cis- and trans- octahydropyridopyrrolobenzheterocycles
US4985420A (en) 1987-12-10 1991-01-15 Duphar International Research B.V. 1,7-annelated indolecarboxylic acid esters and -amides
US4938949A (en) * 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
ZA902794B (en) * 1989-04-18 1991-04-24 Duphar Int Res New 3-n substituted carbamoyl-indole derivatives
GB8913646D0 (en) * 1989-06-14 1989-08-02 Glaxo Group Ltd Chemical compounds
HUT61548A (en) * 1990-08-27 1993-01-28 Sandoz Ag Process for producing indolonaphthyridine derivatives and pharmaceutical compositions comprising such compounds
AU4929999A (en) * 1998-07-30 2000-02-21 Japan Tobacco Inc. Disubstituted maleimide compounds and medicinal utilization thereof
PE20010052A1 (es) 1999-04-23 2001-01-27 Upjohn Co Compuestos de azepinindol tetraciclico como agonistas o antagonistas del receptor de 5-ht
AR024378A1 (es) 1999-06-15 2002-10-02 Du Pont Pharm Co Gamma-carbolinas fusionadas heterociclicas sustituidas

Similar Documents

Publication Publication Date Title
JP2003516325A5 (OSRAM)
EP1816913A4 (en) NEW COMPOUNDS FOR THE TREATMENT OF CANCER AND ILLNESS IN CONNECTION WITH THE ANGIOGENIC FUNCTION
JP2007514005A5 (OSRAM)
FR19C1005I2 (fr) Nano-corps ameliores (tm) pour le traitement des troubles lies a l'agregation
WO2001097786A3 (en) Benzothiazole derivatives
JP2005506370A5 (OSRAM)
JP2007514637A5 (OSRAM)
JP2011522816A5 (OSRAM)
JP2007502287A5 (OSRAM)
JP2002523491A5 (OSRAM)
JP2024504252A5 (OSRAM)
NO20050883L (no) Ny fremgangsmate for syntesen (IS)-4,5-dimetoksy-1-(metylaminometyl)-benzocyklobutan og addisjonssalter derav, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre
JP2004526788A5 (OSRAM)
WO2005084655A8 (en) 1-aminocyclohexane derivatives for the treatment of agitation and other behavioral disorders, especially those associated with alzheimer’s disease
MXPA04005444A (es) Ureas de 2-aminobenzotiazoles como moduladores de adenosina.
NZ598083A (en) New compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine
JP2005530787A5 (OSRAM)
JP2023073373A5 (OSRAM)
JP2008513510A5 (OSRAM)
DE502005010170D1 (de) Neue langwirksame beta-2-agonisten, und deren verwendung als arzneimittel
JP2002542248A5 (OSRAM)
WO2007038112A3 (en) Combination of rosiglitazone and donepezil for improvement of cognitive function
EP1539136A4 (en) PPAR ALPHA SELECTIVE COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEMIA AND OTHER LIPID DISORDERS
JP2008535834A5 (OSRAM)
TW200613255A (en) Therapeutic diphenyl ether ligands